Profound Medical Corp.
PRN.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.37M | 4.18M | 3.14M | 3.26M | 2.87M |
| Total Other Revenue | 9.73M | 10.12M | 8.70M | 8.60M | 8.24M |
| Total Revenue | 16.10M | 14.30M | 11.84M | 11.86M | 10.68M |
| Cost of Revenue | 4.71M | 3.93M | 3.62M | 3.84M | 3.64M |
| Gross Profit | 11.39M | 10.36M | 8.22M | 8.02M | 7.04M |
| SG&A Expenses | 32.05M | 31.62M | 30.82M | 26.55M | 23.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.35M | 56.53M | 54.16M | 48.21M | 43.74M |
| Operating Income | -41.25M | -42.23M | -42.32M | -36.35M | -33.06M |
| Income Before Tax | -42.32M | -39.36M | -40.69M | -31.96M | -27.82M |
| Income Tax Expenses | 252.00K | -12.00K | 44.00K | -1.00K | -2.00K |
| Earnings from Continuing Operations | -42.57 | -39.34 | -40.73 | -31.96 | -27.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.57M | -39.34M | -40.73M | -31.96M | -27.82M |
| EBIT | -41.25M | -42.23M | -42.32M | -36.35M | -33.06M |
| EBITDA | -40.69M | -41.54M | -41.56M | -35.50M | -32.13M |
| EPS Basic | -1.41 | -1.34 | -1.45 | -1.21 | -1.13 |
| Normalized Basic EPS | -0.88 | -0.84 | -0.91 | -0.76 | -0.70 |
| EPS Diluted | -1.41 | -1.34 | -1.45 | -1.21 | -1.13 |
| Normalized Diluted EPS | -0.88 | -0.84 | -0.91 | -0.76 | -0.70 |
| Average Basic Shares Outstanding | 120.77M | 115.97M | 110.40M | 104.79M | 99.04M |
| Average Diluted Shares Outstanding | 120.77M | 115.97M | 110.40M | 104.79M | 99.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |